TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981 May 29, 1981
